VitaSpring Biomedical Co. Ltd.
VSBC · OTC
1/31/2023 | 1/31/2022 | 1/31/2021 | 1/31/2020 | |
|---|---|---|---|---|
| Market Cap | $3 | $3 | $1 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $3 | $3 | $1 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -100% | 2,161.6% | 1,539.4% | – |
| Gross Profit | -$0 | $0 | $0 | $0 |
| % Margin | – | 36.8% | 45.2% | 11.2% |
| EBITDA | -$0 | $0 | -$0 | -$0 |
| % Margin | – | 26.6% | -170.9% | -125.7% |
| Net Income | -$0 | $0 | -$0 | $0 |
| % Margin | – | 22.5% | -171.4% | 45.7% |
| EPS Diluted | -0.02 | 0.006 | -0.005 | 0 |
| % Growth | -431.1% | 229.8% | -1,275% | – |
| Operating Cash Flow | -$0 | $0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | $0 | $0 |
| Free Cash Flow | -$0 | $0 | -$0 | -$0 |